A carregar...
Intravitreal Bevacizumab Versus Ranibizumab for Treatment of Neovascular Age-Related Macular Degeneration: Findings from a Cochrane Systematic Review
TOPIC: To summarize the relative effects of bevacizumab (Avastin®, Genentech, Inc.) and ranibizumab (Lucentis®, Genentech, Inc.), using findings from a Cochrane Eyes and Vision Group systematic review . CLINICAL RELEVANCE: Neovascular age-related macular degeneration (NVAMD) is the most common cause...
Na minha lista:
| Publicado no: | Ophthalmology |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4695272/ https://ncbi.nlm.nih.gov/pubmed/26477843 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ophtha.2015.09.002 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|